About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker INCY

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 6, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale48,576$119.66$5.8M SaleForm 4 ↗
Nov 6, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale73,969$119.12$8.8M SaleForm 4 ↗
Nov 6, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale60,270$118.27$7.1M SaleForm 4 ↗
Nov 6, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale22,336$117.15$2.6M SaleForm 4 ↗
Nov 6, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale35,042$116.06$4.1M SaleForm 4 ↗
Nov 3, 2026Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale610$118.96$72.6K SaleForm 4 ↗
Oct 15, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale2,642$112.71$297.8K SaleForm 4 ↗
Sep 15, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale13,985$120.49$1.7M SaleForm 4 ↗
Sep 15, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale9,233$120.50$1.1M SaleForm 4 ↗
Aug 19, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale10,801$125.56$1.4M SaleForm 4 ↗
Aug 12, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale10,803$120.04$1.3M SaleForm 4 ↗
Aug 5, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale2,207$123.99$273.6K SaleForm 4 ↗
Aug 5, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale10,640$122.69$1.3M SaleForm 4 ↗
Aug 3, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale6,055$120.43$729.2K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale2,293$119.41$273.8K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale326$121.69$39.7K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale85$122.19$10.4K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale1,642$119.38$196.0K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale1,643$119.51$196.4K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale2,864$119.40$342.0K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale4,695$119.39$560.5K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale6,171$119.43$737.0K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale2,187$119.47$261.3K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale5,332$119.42$636.7K SaleForm 4 ↗
Jul 31, 2026Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale14,661$119.46$1.8M SaleForm 4 ↗
Jul 31, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale15,888$119.70$1.9M SaleForm 4 ↗
Jul 16, 2026Mohamed Khairie Issa
EVP, Head of U.S. Commercial
INCY
Incyte Corporation
Sale1,093$115.01$125.7K SaleForm 4 ↗
Jul 16, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale1,877$114.73$215.3K SaleForm 4 ↗
Jul 15, 2026Steven H. Stein
CMO & Head of Late-Stage Dev.
INCY
Incyte Corporation
Sale28,237$113.05$3.2M SaleForm 4 ↗
Jun 4, 2026Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale2,639$100.00$263.9K SaleForm 4 ↗
May 26, 2026Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale2,051$97.35$199.7K SaleForm 4 ↗
May 19, 2026Paul J. Clancy
Director
INCY
Incyte Corporation
Sale15,000$94.93$1.4M SaleForm 4 ↗
Apr 17, 2026Pablo J. Cagnoni
President, Global Head of R&D
INCY
Incyte Corporation
Sale18,667$96.50$1.8M SaleForm 4 ↗
Mar 17, 2026Pablo J. Cagnoni
President, R&D
INCY
Incyte Corporation
Sale18,667$94.24$1.8M SaleForm 4 ↗
Feb 19, 2026Pablo J. Cagnoni
President, R&D
INCY
Incyte Corporation
Sale18,668$100.91$1.9M SaleForm 4 ↗
Jan 7, 2026Mohamed Khairie Issa
EVP, Head of US Oncology
INCY
Incyte Corporation
Sale10,856$109.07$1.2M SaleForm 4 ↗
Jan 5, 2026Steven H. Stein
EVP & Chief Medical Officer
INCY
Incyte Corporation
Sale15,634$101.70$1.6M SaleForm 4 ↗
Dec 19, 2025Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale2,774$100.00$277.4K SaleForm 4 ↗
Dec 18, 2025Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale600$98.25$59.0K SaleForm 4 ↗
Dec 17, 2025Michael James Morrissey
EVP, Head of Tech. Operations
INCY
Incyte Corporation
Sale4,323$97.26$420.5K SaleForm 4 ↗
Dec 16, 2025Michael James Morrissey
EVP, Head of Tech. Operations
INCY
Incyte Corporation
Sale53,175$97.29$5.2M SaleForm 4 ↗
Dec 16, 2025Michael James Morrissey
EVP, Head of Tech. Operations
INCY
Incyte Corporation
Sale833$97.42$81.2K SaleForm 4 ↗
Dec 11, 2025Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale255$94.94$24.2K SaleForm 4 ↗
Dec 10, 2025Patrick A. Mayes
EVP & Chief Scientific Officer
INCY
Incyte Corporation
Sale5,553$95.58$530.8K SaleForm 4 ↗
Dec 2, 2025Steven H. Stein
EVP & Chief Medical Officer
INCY
Incyte Corporation
Sale20,105$102.51$2.1M SaleForm 4 ↗
Dec 1, 2025Steven H. Stein
EVP & Chief Medical Officer
INCY
Incyte Corporation
Sale2,559$102.96$263.5K SaleForm 4 ↗
Nov 24, 2025Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale600$103.00$61.8K SaleForm 4 ↗
Nov 21, 2025Thomas Tray
Principal Accounting Officer
INCY
Incyte Corporation
Sale169$102.00$17.2K SaleForm 4 ↗
Nov 17, 2025Sheila A. Denton
EVP & General Counsel
INCY
Incyte Corporation
Sale278$104.36$29.0K SaleForm 4 ↗
Nov 10, 2025Herve Hoppenot
Director
INCY
Incyte Corporation
Sale187,500$105.46$19.8M SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:18 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances